Podcasts about woolcock institute

Professor Guy Marks AO FAHMS is a distinguished respiratory and public health physician and environmental epidemiologist. Currently serving as the President and interim Executive Director of the International Union Against Tuberculosis and Lung Disease (The Union), he has led the Respiratory and Environmental Epidemiology group at the Woolcock Institute since 1997. His research primarily focuses on lung health, with particular emphasis on airway diseases, air pollution, and tuberculosis. Additionally, he is dedicated to capacity building in lung health research. In this episode, we delve into the essential factors for TB elimination, emphasizing the need for clinicians, researchers, and policymakers to focus on the infectious nature of TB. We explore the significance of large-scale active case finding, a strategy employed since the early 20th century, and discuss why targeted case-finding should be prioritized in middle- and low-burden countries where it proves most effective.Summary (Unfortunately not included in the audio) Despite extensive eradication efforts comparable to malaria and HIV, TB remains a persistent public health issue. Guy indicated that current metrics suggest we are not on track to meet the 2030-2035 global TB eradication targets. Professor Marks highlights the primary factors required for TB elimination, with emphasis that as clinicians, researchers, and policymakers, we need to centre our approach to TB eradication on the basis infectious nature of TB. Since its use in the early 20th century in Western countries, large-scale active case finding remains a primary strategy in the management of TB. Guy indicates that targeted case-finding should be reserved for middle and low TB burden countries where it is more effective.  Professor Mark's Vietnam-Based Research on TB Transmission shows that in high-burden TB countries: Most TB cases result from recent transmission, and are the largely responsible for driving the epidemic in these settings. Identifying and treating these recently diagnosed cases leads to a rapid reduction in TB incidence across the population.  Feasibility and cost remain as the prohibitive challenges for implementing molecular techniques widely in TB case identification. However, advances in radiographic technology are helping to bridge this gap, especially in high TB settings.  Professor Mark's suggests that the essential approach to achieving TB eradication will revolve around finding patients with TB and delivering efficient and effective healthcare.

As we grapple with the increasing consequences of climate change, experts are warning that it's not just an environmental issue, declaring it the ‘biggest global health threat of the 21st century'. In the face of these warnings, where does Australia stand in its preparedness to address these health challenges, both locally and globally? In a discussion led by ABC's climate and health reporter, Tegan Taylor, hear from experts on how disasters such as bushfires and droughts, which are heightened by climate change, are triggering a spectrum of health risks - from infectious diseases to respiratory issues, and mental health challenges - with the vulnerable minority and at-risk groups bearing a disproportionate burden. Panelists included Dr Georgia Behrens MD MScPH, Assistant Director, National Health, Sustainability and Climate Unit; Scientia Professor Guy Marks AO, physician and epidemiologist, Woolcock Institute of Medical Research and UNSW Medicine & Health; Professor Ben Newell, Director, Institute for Climate Risk and Response, UNSW Sydney; and Dr Chloe Watfern, research fellow, Black Dog Institute. Tegan Taylor, award-winning health and science reporter at the ABC, facilitated the discussion. This event was a collaboration between UNSW Medicine & Health and UNSW Science.See omnystudio.com/listener for privacy information.

Whether you're perimenopausal, or post-menopausal, you may still be visited by the seven fairies of menopause. You know:  Itchy, Bitchy, Sleepy, Sweaty, Foggy, Bloaty and Psycho. But the two that really drive us nuts are Sleepy and Sweaty. We need help! Associate Professor and doctor Delwyn Bartlett is a health psychologist at the Woolcock Institute of Medical Research (WIMR) and at University of Sydney. She works in sleep medicine as a researcher in the search to understand sleep disorders and to develop better treatment interventions. Delwyn is a woman of a certain age, so she's living with these challenges herself.  Doctor  Delwyn Bartlett has something to tell us about sleep and being a woman, or man, of a certain age.   Thank you for listening! Share us and give us a review!Website: www.womenofacertainage.com.auPodcast platforms: https://linktr.ee/woacertainageFacebook and Instagram on @woacertainageTikTok at @womenofacertainage Women of a Certain Age is #9 in the world for podcasts for women over 50 (Podchaser, Dec 2022)!

New research has found vape residue clings to furniture, car interiors and walls and remains toxic for up to a month- even worse than cigarettes! Kids are particularly affected because they're more likely to put their hands in their mouths and it goes to their lungs. In this episode of The Briefing, Katrina Blowers gets the low-down from The Woolcock Institute's Professor Brian Oliver about just how bad vape residue is, and what we can do to protect ourselves.   Headlines: Albanese to announce inquiry into Covid response Alan Joyce could lose half his pay cheque Firefighters on high alert   Follow The Briefing:Instagram: @thebriefingpodcast Facebook: TheBriefingNewsAUTwitter: @TheBriefingAUSee omnystudio.com/listener for privacy information.

Why do we need to sleep? What happens when we sleep? How does sleep help us learn? And most importantly, how can we get a good night's sleep?  In this episode, Anika and Esther catch up with sleep expert Delwyn Bartlett from the University of Sydney and the Woolcock Institute of Medical Research.  Enjoy a new episode every fortnight, and if YOU have a big Fact Detective question, send it to factdetectives@kinderling.com.au   Guest: Delwyn Bartlett - Clinical Associate Professor at the University of Sydney Central Clinical School and the Woolcock Institute of Medical Research. Hosts: Anika and Esther  Production: Cinnamon Nippard  Sound design: Josh Newth  Executive Producer: Lorna Clarkson   Hear it first on LiSTNR.   Listen ad-free on Kinderling.  See omnystudio.com/listener for privacy information.

In this week's episode, we bring you a panel discussion on how the vaccine champions programme has empowered community leaders to advocate for COVID-19 vaccines in Australia, Vietnam, and Fiji. You will hear from three vaccination experts and leaders who are all involved in an innovative behavioural change programme known as Vaccine Champions, which was developed in Victoria, Australia and has recently been rolled out in Fiji and Vietnam.On the panel:Sr Litiana Volavola, National Program Manager for the Expanded Program on Immunization (EPI) and Supply Chain and Fiji COVID-19 Vaccination Team LeadProfessor Thu Anh Nguyen from the Woolcock Institute of Medical Research in VietnamProfessor Margie Danchin, Group Leader, Vaccine Uptake, Murdoch Children's Research InstituteIn this episode we discuss the results from the implementation of the vaccine champions programme in Australia and how it has been rolled out in Vietnam and Fiji, including:  An overview of the vaccine champions programme and what it means to be a vaccine champion. The challenges and barriers to achieving high vaccine coverage in the community such as access and acceptance. Learnings from recent trainings in Vietnam and Fiji and how the programme is supporting community leaders to advocate for COVID-19 vaccines in their communities. We encourage you to join the conversation at @CentreHealthSec. You also access the paper Vaccine Champions Training Program: Empowering Community Leaders to Advocate for COVID-19 Vaccines here: https://www.mdpi.com/2076-393X/10/11/1893

Whether you're perimenopausal, or post-menopausal, you may still be visited by the 7 fairies of menopause. You know, itchy, bitchy, sleepy, sweaty, foggy, bloaty and psycho. But the two that drive us nuts are sleepy and sweaty. We need help! Associate Professor and Doctor Delwyn Bartlett is a health psychologist at the Woolcock Institute of Medical Research (WIMR) and at University of Sydney. She works in sleep medicine as a researcher in the quest to understand sleep disorders and develop better treatment interventions. And she is a woman of a certain age, so she's lived with these challenges herself.  Delwyn has something to tell us about sleep and being a woman or man of a certain age.  

The management of severe depression and sleep disorders Suicidal ideation and several other issues that present to GPs regularly if not frequently A stepped approach to managing the severely depressed patient with sleep disorder and suicidal thoughts Host: Dr David Lim | Total time: 35 mins Guest: Dr Chris Blackwell, Psychiatrist; The Woolcock Institute of Medical Research Register for our fortnightly FREE WEBCASTS Every second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next one See omnystudio.com/listener for privacy information.

The current indications and contraindications for home oxygen therapy/long term domiciliary oxygen therapy When to think about more invasive treatments - The criteria behind identifying patients for lung reduction surgery Host: Dr David Lim | Total time: 36 mins Guest: Dr Chris Blackwell, Psychiatrist; The Woolcock Institute of Medical Research Register for our fortnightly FREE WEBCASTS Every second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next one See omnystudio.com/listener for privacy information.

We must first treat the sleep disorder if we want to significantly help the management of the depression A very clear structured guide for GPs to manage these patients Host: Dr David Lim | Total time: 24 mins Guest: Dr Chris Blackwell, Psychiatrist; The Woolcock Institute of Medical Research Register for our fortnightly FREE WEBCASTS Every second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next one See omnystudio.com/listener for privacy information.

In this Healthed lecture, Dr Chris Blackwell, Psychiatrist; The Woolcock Institute of Medical Research, Sydney, addresses the common questions surrounding the treatment for sleep and depression, as he presents the latest evidence on the interplay between these two conditions and outlines a practical approach to their assessment and management. See omnystudio.com/listener for privacy information.

The following episode is a Feed Play Love highlight episode, back due to popular demand.It can be very unsettling when your child wakes up in the middle of the night terrified and crying. It can be very difficult to calm and console them. So how do you know if they are having a nightmare or a night terror? Dr Chris Seton is a paediatric and adolescent sleep specialist at the Woolcock Institute. In this interview from our archives he explains what a night terror looks like and what to do about it.

Do you ever feel more exhausted after the weekend than before it? You can blame that extra snooze you had. A study has found that lazy Saturday and Sunday lie-ins can disturb your body clock leaving you fatigued at the start of the week. So how can you play catchup now? Links Here's why you hate Mondays, The Age https://bit.ly/3a6gDoq Not Sleeping? The Best Insomnia Cure Could Be To Ignore It, Dr Christopher Miller from the Woolcock Institute of Medical Research https://bit.ly/3wPemrv Follow us on Instagram @thespace_podcast CreditsHost: Casey Donovan @caseydonovan88Content: Amy Molloy @amy_molloyExecutive Producer: Elise CooperEditor: Will RyanSee omnystudio.com/listener for privacy information.

In this episode:  Sleep deprivation affects about 70% of teenagers Impacts adversely on academic performance, mood issues especially depression and anxiety. Two red flag questions will help GPs identify when a child has sleep deprivation. Practical advice on how to manage, when to refer, online management resources   Host: Dr David Lim | Total time: 36 mins Guest: Dr Chris Seton, Paediatric and Adolescent Sleep Physician; Staff Specialist, Woolcock Institute of Medical Research    Register for our upcoming FREE WEBCAST Tuesday 2 February 2020 | 7:00pm-9:00pm AEDT Click here to register now! See omnystudio.com/listener for privacy information.

In this week’s episode we discuss Vietnam’s response to the COVID-19 pandemic and antimicrobial drug resistance with Dr Guy Thwaites, Director of the Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Program in Vietnam, Dr Thu Anh Nguyen, Country Director, Woolcock Institute and Clinical Senior Lecturer at University of Sydney and Dr Gregory Fox, Project lead for the Indo-Pacific Centre for Health Security’s AMR V-RESIST project in Vietnam and Clinical Academic Lead (Research) for the Faculty of Medicine and Health at Cumberland Campus.Since this interview was recorded, Vietnam has recorded a large outbreak in the coastal city of Da Nang. As discussed by our guests, the government is taking early action when cases are identified. In the case of Da Nang they imposed an immediate lockdown and have launched widespread testing of the city’s 1.1 million residents.

Pretty much every week, we get an email from a new cannabis startup, promoting their latest CBD or THC remedy to treat any number of health conditions, including sleep problems. This boom in new, legal cannabis products is the result of recent legislation to start the process of widespread marijuana decriminalisation, and eventually full legalisation. But whilst the consumer demand is fuelling massive growth in the global cannabis industry, currently, there's little, verging on zero clinical evidence to firmly substantiate many of the health claims made by the new wave of cannabis products hitting the market. So in this episode, we go behind the marketing claims, and look at the real, solid, scientific evidence behind medical cannabis and its efficacy in treating insomnia and a whole host of other sleep disorders including sleep apnea, restless legs syndrome, and even narcolepsy. This episode's guest:   Anastasia Suraev is a clinical research officer at the Lambert Initiative for Cannabinoid Therapeutics, a philanthropically-funded centre for cannabinoid research at the University of Sydney. She is also a PhD candidate at the Woolcock Institute of Medical Research where she is leading a clinical trial assessing the effects of a cannabis-based therapy on sleep in people with chronic insomnia. University of Sydney: https://www.sydney.edu.au/science/about/our-people/academic-staff/anastasia-suraev.html Lambert Initiative for Cannabinoid Therapeutics: https://www.sydney.edu.au/lambert/: Systematic Review: Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies Episode Homepage: http://sleepjunkies.com/cannabis-sleep-medicine/ More Episodes:

Pretty much every week, we get an email from a new cannabis startup, promoting their latest CBD or THC remedy to treat any number of health conditions, including sleep problems. This boom in new, legal cannabis products is the result of recent legislation to start the process of widespread marijuana decriminalisation, and eventually full legalisation. But whilst the consumer demand is fuelling massive growth in the global cannabis industry, currently, there's little, verging on zero clinical evidence to firmly substantiate many of the health claims made by the new wave of cannabis products hitting the market. So in this episode, we go behind the marketing claims, and look at the real, solid, scientific evidence behind medical cannabis and its efficacy in treating insomnia and a whole host of other sleep disorders including sleep apnea, restless legs syndrome, and even narcolepsy. This episode's guest:   Anastasia Suraev is a clinical research officer at the Lambert Initiative for Cannabinoid Therapeutics, a philanthropically-funded centre for cannabinoid research at the University of Sydney. She is also a PhD candidate at the Woolcock Institute of Medical Research where she is leading a clinical trial assessing the effects of a cannabis-based therapy on sleep in people with chronic insomnia. University of Sydney: https://www.sydney.edu.au/science/about/our-people/academic-staff/anastasia-suraev.html Lambert Initiative for Cannabinoid Therapeutics: https://www.sydney.edu.au/lambert/: Systematic Review: Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies Episode Homepage: https://sleepjunkies.com/cannabis-sleep-medicine/ More Episodes:

In this Episode: There are 3 kinds of masks, each with pros and cons What happens if you wash the mask? Some social distancing case studies Host: Dr David Lim, GP Guest: A/Prof Euan Tovey, Associate Professor & Principal Research Fellow, Central Clinical School, Woolcock Institute of Medical Research; University of Sydney Total time:  30 mins See omnystudio.com/listener for privacy information.

In this Episode: The letter to the WHO… why the 1.5m rule is probably wrong Small droplet transmission (aerosol) travels much further than 1.5m and explains super spreading events Why so much disagreement on masks? What can GPs do? Host: Dr David Lim, GP Guest: A/Prof Euan Tovey, Associate Professor & Principal Research Fellow, Central Clinical School, Woolcock Institute of Medical Research; University of Sydney Total time:  29 mins See omnystudio.com/listener for privacy information.

It's not the most relaxing way to fall asleep - wired up in a hospital bed and monitored via several cameras - but Hack's James Purtill was willing to be studied at Sydney's Woolcock Institute so we could talk about the connection between sleep and health Plus, why Trump's spruiking an anti-malaria drug as his prevention plan for COVID-19 despite it being completely unproven. And, what's actually going on between Australia and China right now.

Prof Sinthia Bosnic-Anticevich from the Faculty of Medicine and Health at Woolcock Institute of Medical Research takes an in-depth look at inhaler devices in this Healthed lecture. 

Helen Reddel, from the Woolcock Institute of Medical Research in Sydney Australia and Chair of the Science Committee of the Global Initiative for Asthma, GINA, brings us up to date with some of the changes in the GINA 2020 report, which was published in early April and is available for download from the GINA website: www.ginasthma.org

Focussing on the management of asthma with Helen Reddel, Chair of the GINA Science Committee and a research leader at the Woolcock Institute of Medical Research in Sydney, Australia.

Difficulty sleeping is a common presenting problem in primary practice. While sleep disruption can at times be a symptom of an underlying medical or psychological disorder, poor sleep can also negatively impact overall health and wellbeing. Panel members: Prof Ron Grunstein, Professor of Sleep Medicine, Woolcock Institute of Medical Research, University of Sydney and RoyalContinue reading "Insomnia"

Not to be confused with nightmares, night terrors can be terrifying for parents to witness. Paediatric and adolescent sleep specialist Dr Chris Seaton from the Woolcock Institute tells us how to handle them. Firstly, don't try to wake them!

Dr Chris Seaton is a Paediatric and Adolescent Sleep Physician from the Woolcock Institute who open up about the time of night we're prone to getting nightmares, possible ways to avoid them, and how to help your little one if their nightmares are recurring.

Chris is joined by Dr Ron Grunstein, a professor of sleep medicine at The University of Sydney’s Woolcock Institute. Ron’s interest in sleep began when he did his postgraduate training at Stanford University Sleep Laboratory. His first patient was an anesthetist with narcolepsy, a condition that caused him to fall asleep and collapse suddenly while in surgery. Ron was immediately fascinated and this kick started his 40 year career in the field. Chris and Ron discuss the latest research on the science of sleep, detangling fact from fiction and exposing the big business of big sleep. For full transcript and additional resources visit: http://sydney.edu.au/news-opinion/news/2016/07/13/the-big-sleep--what-it-is-and-how-to-get-more.html

Difficulty sleeping is a common presenting problem in primary practice. While sleep disruption can at times be a symptom of an underlying medical or psychological disorder, poor sleep can also negatively impact overall health and wellbeing. Panel members: Prof Ron Grunstein, Professor of Sleep Medicine, Woolcock Institute of Medical Research, University of Sydney and Royal Prince Alfred Hospital; Dr Elizabeth Mason, Clinical & Research Psychologist, Clinical Research Unit for Anxiety and Depression, St Vincent's Hospital; Dr Aliza Werner-Seidler, Research Fellow & Clinical Psychologist, Black Dog Institute; Shirley Sneddon, Lived Experience Representative Facilitated by: Dr Vered Gordon, Black Dog Institute GP Consultant Recording and sound production: James Stewart, audioPost Voiceover: Cameron Banks, Black Dog Institute

Read the full story with photos at  https://www.otsuka.co.jp/en/company/globalnews/detail.php?id=225&date=2015-12-21   Dr. Gregory Fox from Sydney, Australia was presented the Young Innovator in Tuberculosis Research Award sponsored by Otsuka during the 46th Union World Conference on Lung Health in Cape Town, South Africa in December 2015. Dr. Fox is an Australian respiratory physician and recipient of the CJ Martin Fellowship from the Australian Government. His research focuses on TB case-finding and multidrug-resistant TB in high-burden settings. Dr. Fox was the foundation country director of the Woolcock Institute of Medical Research in Vietnam from 2009 to 2013. During that period, in partnership with the Vietnam National TB Program, he implemented a randomized controlled trial (the ACT2 study), screening over 25,000 people for TB. The project was innovative in its use of randomized controlled trial methodology and electronic tools that were developed especially for the trial and are scalable. Additionally, the project demonstrated the feasibility of centrally coordinated tracing of everyone who has come in contact with a person diagnosed with TB. Currently, Dr. Fox is an investigator on several ongoing public health and clinical studies of TB screening and prevention in Vietnam. He also works as a respiratory physician at Royal Prince Alfred Hospital in Sydney, Australia. The Young Innovator in TB Research Award was established through a global partnership between Otsuka Pharmaceutical and The Union. The award is administered by The Union with a grant provided by Otsuka. Award recipients are selected by a panel of experts organised independently by The Union. The purpose of the award is to stimulate the advancement of innovative approaches in TB control and patient care. The award is open to young clinicians who have documented achievements in the formulation and implementation of clinical and operational research in the field of TB or multidrug-resistant TB.

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts, in which chief editor Marc Humbert discusses the new GINA guidelines for asthma control with Prof. Helen K. Reddel from the Woolcock Institute of Medical Research, University of Sydney, Australia.

Read the full story with photos at: http://www.otsuka.co.jp/en/company/globalnews/detail.php?id=225&date=2016-02-01 Dr. Gregory Fox from Sydney, Australia was presented the Young Innovator in Tuberculosis Research Award sponsored by Otsuka during the 46th Union World Conference on Lung Health in Cape Town, South Africa in December 2015. Dr. Fox is an Australian respiratory physician and recipient of the CJ Martin Fellowship from the Australian Government. His research focuses on TB case-finding and multidrug-resistant TB in high-burden settings. Dr. Fox was the foundation country director of the Woolcock Institute of Medical Research in Vietnam from 2009 to 2013. During that period, in partnership with the Vietnam National TB Program, he implemented a randomized controlled trial (the ACT2 study), screening over 25,000 people for TB. The project was innovative in its use of randomized controlled trial methodology and electronic tools that were developed especially for the trial and are scalable. Additionally, the project demonstrated the feasibility of centrally coordinated tracing of everyone who has come in contact with a person diagnosed with TB. Currently, Dr. Fox is an investigator on several ongoing public health and clinical studies of TB screening and prevention in Vietnam. He also works as a respiratory physician at Royal Prince Alfred Hospital in Sydney, Australia. Encouraging Young Researchers for the Continuation of Actions Against TB The Young Innovator in TB Research Award was established through a global partnership between Otsuka Pharmaceutical and The Union. The award is administered by The Union with a grant provided by Otsuka. Award recipients are selected by a panel of experts organised independently by The Union. The purpose of the award is to stimulate the advancement of innovative approaches in TB control and patient care. The award is open to young clinicians who have documented achievements in the formulation and implementation of clinical and operational research in the field of TB or multidrug-resistant TB.